CN102949672A - Medicine for treating pelvic inflammation - Google Patents
Medicine for treating pelvic inflammation Download PDFInfo
- Publication number
- CN102949672A CN102949672A CN2012104918526A CN201210491852A CN102949672A CN 102949672 A CN102949672 A CN 102949672A CN 2012104918526 A CN2012104918526 A CN 2012104918526A CN 201210491852 A CN201210491852 A CN 201210491852A CN 102949672 A CN102949672 A CN 102949672A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- pelvic inflammation
- medicines
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine, in particular to a medicine for treating pelvic inflammation, which is prepared from the traditional Chinese medicine as the raw material. The purpose of the medicine aims to perform the traditional Chinese medicine compatibility of medicines, and the human body function is comprehensively regulated. The invention has the technical scheme that the medicine for treating the pelvic inflammation is prepared from the following medicines as the raw material medicine in parts by weight: 20-30 parts of euphorbia humifusa, 15-20 parts of radix zanthoxyli, 15-20 parts of cortex lycii radicis, 10-15 parts of rhizoma sparganii, 10-15 parts of curcuma zedoary, 25-35 parts of honeysuckle and 25-35 parts of oldenlandia diffusa. The medicine for treating pelvic inflammation has the advantages that both symptoms and root causes are treated, no resistance to medicines is generated, and the treatment course is short.
Description
Technical field
The present invention relates to a kind of medicine, particularly relate to a kind of medicine of the treatment pelvic inflammatory disease for preparing take Chinese medicine as raw material.
Background technology
Female pelvic cavity genitals and connective tissue on every side thereof when pelvic peritoneum is inflamed, are called pelvic inflammatory disease, comprise metritis, adnexitis, inflammation of pelvic connective tissue and pelvioperitonitis, can a place or a few place fall ill simultaneously, be one of commonly encountered disease.. cardinal symptom: how not obvious (1) General Symptoms is, sometimes low grade fever can be arranged, and susceptible is tired.The course of disease time, some patients were can have neurasthenia symptom than the elder, such as lassitude, whole body discomfort, insomnia etc.When patient's resistance is poor, acute or subacute outbreak is arranged easily.(2) cicatricial adhesion and the pelvic congestion that form of chronic inflammatory disease can cause that the hypogastric region pendant is swollen, pain and lumbosacral region ache.Be everlasting after fatigue, the sexual intercourse and menstruation before and after aggravation.(3) owing to pelvic congestion, the patient can have menstruation to increase; During the ovarian function infringement menoxenia can be arranged; Fallopian tube adhesion can cause infertile when blocking.If treat at present drug main Western medicine and the Chinese medicine of pelvic inflammatory disease, for a long time use of Western medicine can be developed immunity to drugs, and drug dependence is strong, easily repeatedly; Chinese medicine exists can not treating both the principal and secondary aspects of a disease, the problem that the course for the treatment of is long.
Summary of the invention
The objective of the invention is to bring into play traditional Chinese medical science combination drug, across-the-board regulation bodily fuctions's characteristics provide a kind for the treatment of both the principal and secondary aspects of a disease, can not develop immunity to drugs, the medicine of the treatment pelvic inflammatory disease of short treating period.
The technical scheme that the present invention takes for achieving the above object is:
A kind of medicine for the treatment of pelvic inflammatory disease be medicine take following portions by weight as crude drug:
Radix seu Caulis Parthenocissi tricuspidatae 20～30, Radix Zanthoxyli 15～20, Cortex Lycii 15～20, rhizoma sparganic 10～15, Rhizoma Curcumae 10～15, Flos Lonicerae 25～35, Herba Hedyotidis Diffusae 25～35.
Medicine of the present invention can be made any dosage form on the pharmaceutics, such as decoction, tablet, pill, powder, capsule;
The preferred dosage form of the present invention is decoction.Concrete preparation method is: said medicine is put in the medicinal cupping, decocts with water 3 times according to conventional method, and each 1～2 hour, merge 3 times decocting liquid, filter, sterilizing makes product.
In the prescription of the present invention, Radix seu Caulis Parthenocissi tricuspidatae has invigorates blood circulation, and dispels the wind the effect of pain relieving; Radix Zanthoxyli have dispel the wind, the effect of collateral dredging, detumescence, pain relieving; Cortex Lycii has removing heat from blood except effect precious, the lung heat clearing pathogenic fire reducing; Rhizoma sparganic has removing blood stasis, circulation of qi promoting, the effect of removing food stagnancy pain relieving; Rhizoma Curcumae has the effect of removing blood stasis promoting the circulation of QI to relieve pain, long-pending eliminating stagnation, removing blood stasis; Flos Lonicerae has the effect of heat-clearing and toxic substances removing, wind-heat dissipating; Herba Hedyotidis Diffusae has the effect of heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, promoting urination to remove dampness.
The present invention randomly draws 300 routine Patients with Pelvic Inflammatory Diseases, adopts medicine of the present invention to treat, and conclusion is that effective percentage reaches 99%, and wherein cure rate reaches 94.7%, shows that Drug therapy eczema of the present invention is evident in efficacy, has no obvious adverse reaction in the therapeutic process.
The specific embodiment
Embodiment 1
Take by weighing raw material by following proportioning:
Radix seu Caulis Parthenocissi tricuspidatae 20, Radix Zanthoxyli 15, Cortex Lycii 15, rhizoma sparganic 10, Rhizoma Curcumae 10, Flos Lonicerae 25, Herba Hedyotidis Diffusae 25.
Concrete preparation method is: said medicine is put in the medicinal cupping, decocts with water 3 times according to conventional method, and each 1～2 hour, merge 3 times decocting liquid, filter, sterilizing makes medicinal liquid, and is oral, twice on the one.
Embodiment 2
Take by weighing raw material by following proportioning:
Radix seu Caulis Parthenocissi tricuspidatae 25, Radix Zanthoxyli 18, Cortex Lycii 18, rhizoma sparganic 12, Rhizoma Curcumae 12, Flos Lonicerae 30, Herba Hedyotidis Diffusae 30.
Concrete preparation method is: said medicine is put in the medicinal cupping, decocts with water 3 times according to conventional method, and each 1～2 hour, merge 3 times decocting liquid, filter, sterilizing makes medicinal liquid, and is oral, twice on the one.
Embodiment 3
Take by weighing raw material by following proportioning:
Radix seu Caulis Parthenocissi tricuspidatae 30, Radix Zanthoxyli 20, Cortex Lycii 20, rhizoma sparganic 15, Rhizoma Curcumae 15, Flos Lonicerae 35, Herba Hedyotidis Diffusae 35.
Concrete preparation method is: said medicine is put in the medicinal cupping, decocts with water 3 times according to conventional method, and each 1～2 hour, merge 3 times decocting liquid, filter, sterilizing makes medicinal liquid, and is oral, twice on the one.
Claims (1)
1. medicine for the treatment of pelvic inflammatory disease is characterized in that medicine take following portions by weight is as crude drug:
Radix seu Caulis Parthenocissi tricuspidatae 20～30, Radix Zanthoxyli 15～20, Cortex Lycii 15～20, rhizoma sparganic 10～15, Rhizoma Curcumae 10～15, Flos Lonicerae 25～35, Herba Hedyotidis Diffusae 25～35.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104918526A CN102949672A (en) | 2012-11-27 | 2012-11-27 | Medicine for treating pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104918526A CN102949672A (en) | 2012-11-27 | 2012-11-27 | Medicine for treating pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102949672A true CN102949672A (en) | 2013-03-06 |
Family
ID=47759432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104918526A Pending CN102949672A (en) | 2012-11-27 | 2012-11-27 | Medicine for treating pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102949672A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435107A (en) * | 2015-12-22 | 2016-03-30 | 盛庆石 | Traditional Chinese medicine composition used for treating chronic pelvic inflammatory disease, and preparation method thereof |
| CN113521169A (en) * | 2020-04-22 | 2021-10-22 | 中南大学湘雅医院 | Medicinal preparation for treating gynecological inflammation and preparation method thereof |
-
2012
- 2012-11-27 CN CN2012104918526A patent/CN102949672A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 临床医生手册编写组: "《临床医生手册》", 31 July 1979, 湖南科学技术出版社 * |
| 范小艳: "中西医结合治疗盆腔脓肿的临床疗效观察", 《健康必读》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435107A (en) * | 2015-12-22 | 2016-03-30 | 盛庆石 | Traditional Chinese medicine composition used for treating chronic pelvic inflammatory disease, and preparation method thereof |
| CN113521169A (en) * | 2020-04-22 | 2021-10-22 | 中南大学湘雅医院 | Medicinal preparation for treating gynecological inflammation and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103055278B (en) | Medicament for treating rheumatism | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN102205096B (en) | Medicament for treating adnexitis and pelvic inflammation | |
| CN102949672A (en) | Medicine for treating pelvic inflammation | |
| CN102406900B (en) | External traditional Chinese preparation for treating hyperplasia of mammary glands | |
| CN103768368B (en) | A kind of Chinese medicine composition treating acute epididymitis | |
| CN101095730A (en) | Medicine for treating rheumatism atrophic arthritis | |
| CN103784932A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN103585273B (en) | Traditional Chinese medicine composition for treating local swelling and pain | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN105193912A (en) | Traditional Chinese medicine composition for treating acute mastitis and preparation method of traditional Chinese medicine composition | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN102139087A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN105343243A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and nursing method of traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104771528A (en) | Traditional Chinese medicine composition for treating urinary calculi | |
| CN103536717B (en) | Traditional Chinese medicine for treating osteomyelitis as well as preparation method thereof | |
| CN103550620A (en) | External medicinal composition for treating pain from rheumatism | |
| CN103768235A (en) | Traditional Chinese medicinal pills for treating protrusion of lumbar intervertebral disc | |
| CN104138543A (en) | Traditional Chinese medicine for treating epididymitis | |
| CN104013785A (en) | Traditional Chinese medicine oral solution for treating rheumatism | |
| CN104189866A (en) | Externally-used traditional Chinese medicine wine for treating knee joint bone hyperplasia | |
| CN104173930A (en) | Traditional Chinese medicine composition for treating cold-damp lumbago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130306 |